Immunotherapy for hepatocellular carcinoma: Current status and future perspectives

Hepatocellular carcinoma (HCC) is one of the world’s deadliest and fastest-growing tumors, with a poor prognosis. HCC develops in the context of chronic liver disease. Curative resection, surgery (liver transplantation), trans-arterial chemoembolization, radioembolization, radiofrequency ablation an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandlik, Deepa S, Mandlik, Satish K, Choudhary, Heena B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950866/
https://www.ncbi.nlm.nih.gov/pubmed/36844141
http://dx.doi.org/10.3748/wjg.v29.i6.1054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950866/
https://www.ncbi.nlm.nih.gov/pubmed/36844141
http://dx.doi.org/10.3748/wjg.v29.i6.1054

Ejemplares similares